Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy X4 Pharmaceuticals stock

Learn how to easily invest in X4 Pharmaceuticals stock.

X4 Pharmaceuticals Inc is a biotechnology business based in the US. X4 Pharmaceuticals shares (XFOR) are listed on the NASDAQ and all prices are listed in US Dollars. X4 Pharmaceuticals employs 83 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in X4 Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – XFOR – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

X4 Pharmaceuticals stock price (NASDAQ: XFOR)

Use our graph to track the performance of XFOR stocks over time.

X4 Pharmaceuticals shares at a glance

Information last updated 2022-09-27.
Latest market close$1.49
52-week range$0.86 - $6.18
50-day moving average $1.14
200-day moving average $1.52
Wall St. target price$5.40
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.45

Buy X4 Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy X4 Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

X4 Pharmaceuticals price performance over time

Historical closes compared with the close of $1.49 from 2022-09-29

1 week (2022-09-23) 61.96%
1 month (2022-09-01) 43.27%
3 months (2022-07-01) 43.27%
6 months (2022-04-01) -21.16%
1 year (2021-10-01) -71.07%
2 years (2020-10-01) -78.06%
3 years (2019-10-01) 12.54
5 years (2017-09-27) N/A

X4 Pharmaceuticals financials

Gross profit TTM $3 million
Return on assets TTM -45.34%
Return on equity TTM -159.37%
Profit margin 0%
Book value $0.97
Market capitalisation $61.2 million

TTM: trailing 12 months

X4 Pharmaceuticals share dividends

We're not expecting X4 Pharmaceuticals to pay a dividend over the next 12 months.

Have X4 Pharmaceuticals's shares ever split?

X4 Pharmaceuticals's shares were split on a 1:6 basis on 13 March 2019. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your X4 Pharmaceuticals shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for X4 Pharmaceuticals shares which in turn could have impacted X4 Pharmaceuticals's share price.

X4 Pharmaceuticals share price volatility

Over the last 12 months, X4 Pharmaceuticals's shares have ranged in value from as little as $0.86 up to $6.18. A popular way to gauge a stock's volatility is its "beta".

XFOR.US volatility(beta: 0.73)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while X4 Pharmaceuticals's is 0.7279. This would suggest that X4 Pharmaceuticals's shares are less volatile than average (for this exchange).

X4 Pharmaceuticals overview

X4 Pharmaceuticals, Inc. , a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the treatment of CXCR4 disorders and primary immunodeficiencies. It has a license agreement with Abbisko Therapeutics Co. , Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications.

Frequently asked questions

What percentage of X4 Pharmaceuticals is owned by insiders or institutions?
Currently 1.013% of X4 Pharmaceuticals shares are held by insiders and 38.635% by institutions.
How many people work for X4 Pharmaceuticals?
Latest data suggests 83 work at X4 Pharmaceuticals.
When does the fiscal year end for X4 Pharmaceuticals?
X4 Pharmaceuticals's fiscal year ends in December.
Where is X4 Pharmaceuticals based?
X4 Pharmaceuticals's address is: 61 North Beacon Street, Boston, MA, United States, 02134
What is X4 Pharmaceuticals's ISIN number?
X4 Pharmaceuticals's international securities identification number is: US98420X1037
What is X4 Pharmaceuticals's CUSIP number?
X4 Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 042873109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site